Author:
FDA Faces Forward with Flexible Genetic Guidance
In recent years, the FDA has examined a record number of revolutionary medical devices, many of which have been genetic tests. Genetics has taken the world by storm. The medical world continues to look toward genetics as a promising next step in revolutionizing treatment, while the American public has shown a growing interest in learning more about themselves through services like Ancestry and 23andMe. In an effort to gain a foothold on the rapidly developing field of technology, the FDA has recently made efforts to modernize its approach by issuing new guidance to ensure the validity of these tests.
Financing a Funeral: FTC Protection Against Providers
One of the most difficult things many of us will experience in our lifetime is the death of a loved one. Whether unexpected or a drawn out farewell, it is a situation no one can be full prepared to handle. In this moment of extreme vulnerability, most people begin the process of planning a funeral. Society has placed an incredible amount of faith in funeral directors to make sure the wishes of our loved ones are met and insure a memorable service for the living. However, this is not always the case.
Medical Marijuana and Maintaining FDA Compliance
Regardless of opinions on legalization, many people accept the idea that medical marijuana, and more specifically CBD, can be a powerful treatment for many medical conditions. However, there has been one major roadblock: the FDA. According to the FDA, more than 90 warning letters over the past 10 years have been released to companies claiming that their cannabis products cure various symptoms. The most common is the claim that marijuana prevents or treats cancer. In 2017, as the medical properties of marijuana continue to be trumpeted to the general public, the FDA is still working to protect the public by issuing warning letters to marijuana providers making unsubstantiated claims.
Dear Colleague: Collegiate Compliance with Changing Evidentiary Standards of Sexual Misconduct
In a world where sexual assault occurrences on college campuses are becoming more readily recognized and reported, one of the many arising issues is how to appropriately respond to the allegations. Facing college disciplinary boards is one of the principal battlegrounds. With cases of sexual assault often lacking enough evidence for police action, many have demanded that colleges take responsibility for their students’ safety. However, in a situation where it is already “he said, she said,” what is the appropriate evidentiary standard for reprimand?
Harvey Heralds Change: The Combusting Compliance of Emergency Response to Hazardous Materials
In the wake of Hurricane Harvey’s severe flooding, the Arkema chemical plant in Crosby, Texas has made quite the media splash. Rising waters left the plant without power, forcing workers to transfer volatile organic peroxides into large refrigerated trucks with independent generators. In up to six feet of water, several of the trucks’ refrigeration systems failed, resulting in combustion of the hydrogen peroxide, a hazardous material under the Occupational Safety and Health Administration (OSHA) standards. This is not the first example of chemical plants having issues with natural disasters; there were significant hazardous material concerns after Hurricane Katrina in 2005 and more recently the Fukushima nuclear plant in 2011. With no indication that these problems will be resolved, it is important to once again look at regulations placed on chemical plants in response to emergency.